Altamira Therapeutics Ltd. (CYTO)
NASDAQ: CYTO · Real-Time Price · USD
0.425
-0.015 (-3.39%)
Nov 21, 2024, 11:01 AM EST - Market open
Altamira Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1 | 1 | 6 | 27 | 30 | 5 | |
| Market Cap Growth | -18.65% | -75.59% | -78.93% | -10.02% | 459.11% | -65.68% | |
| Enterprise Value | 2 | 5 | 11 | 18 | 30 | -1 | |
| Last Close Price | 0.44 | 3.48 | 97.00 | 726.00 | 1048.00 | 648.00 | |
| PB Ratio | 0.19 | 0.21 | -0.68 | 2.06 | 1.78 | 0.89 | |
| P/TBV Ratio | 1.47 | 0.54 | - | - | 3.91 | - | |
| Debt / Equity Ratio | 0.07 | 0.02 | -0.76 | 0.04 | 0.03 | - | |
| Quick Ratio | 0.15 | 0.78 | 0.06 | 0.34 | 3.74 | 0.71 | |
| Current Ratio | 0.43 | 1.38 | 0.14 | 0.84 | 3.83 | 1.04 | |
| Return on Equity (ROE) | -368.78% | - | -790.08% | -44.88% | -71.91% | -136.94% | |
| Return on Assets (ROA) | -57.15% | -52.83% | -27.56% | -16.70% | -21.99% | -47.50% | |
| Return on Capital (ROIC) | -99.80% | -161.65% | -60.38% | -21.60% | -28.31% | -81.59% | |
| Earnings Yield | -186.83% | -279.57% | -467.82% | -63.38% | -27.41% | -123.96% | |
| FCF Yield | -524.52% | -831.73% | -153.13% | -50.80% | -16.19% | -158.08% | |
| Buyback Yield / Dilution | -1503.64% | -978.83% | -37.50% | -120.26% | - | - | |
| Total Shareholder Return | -1503.64% | -978.83% | -37.50% | -120.26% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.